// App-Quantinova.ai

P680 : Long-term efficacy of ustekinumab with and without concomitant immunosuppressants for Crohn’s disease: results from IM-UNITI long-term extension through 2 years

Researchers

Presenter

  • S Ghosh

Principal Investigators

  • B C Kramer

  • C Gasink

  • D Jacobstein

  • O J Adedokun

  • L-L Gao

  • P Rutgeerts

  • B E Sands

Medical Centers

  • University of Birmingham, Birmingham, United Kingdom

  • Janssen Scientific Affairs, Horsham, PA

  • Janssen Research and Development, LLC, Spring House, PA

  • University Hospital Gasthuisberg, Leuven, Belgium

  • Icahn School of Medicine at Mount Sinai, New York, NY

Locations

  • United Kingdom

  • United States

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Crohn's disease

Biomarkers

  • N/A

Drug/Treatment

  • Ustekinumab

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved